Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 32.

Allen, Christopher M., Feng, Jenny J., Willis, Mark D., McGinley, Marisa, Ontaneda, Daniel, Tallantyre, Emma C. and Evangelou, Nikos 2020. Clinical observation during alemtuzumab administration. Multiple Sclerosis and Related Disorders 37 , 101412. 10.1016/j.msard.2019.101412

Willis, M. D. and Robertson, N. P. 2019. Neurotoxicity of novel cancer immunotherapies. Journal of Neurology 266 (8) , pp. 2087-2089. 10.1007/s00415-019-09444-4

Willis, Mark and Robertson, Neil 2019. Technology-assisted recovery of walking after spinal cord injury. Journal of Neurology 266 (4) , pp. 1046-1048. 10.1007/s00415-019-09227-x

Brown, J. William L., Coles, Alasdair, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Trojano, Maria, Lugaresi, Alessandra, Bergamaschi, Roberto, Grammond, Pierre, Alroughani, Raed, Hupperts, Raymond, McCombe, Pamela, Van Pesch, Vincent, Sola, Patrizia, Ferraro, Diana, Grand'Maison, Francois, Terzi, Murat, Lechner-Scott, Jeannette, Flechter, Schlomo, Slee, Mark, Shaygannejad, Vahid, Pucci, Eugenio, Granella, Franco, Jokubaitis, Vilija, Willis, Mark, Rice, Claire, Scolding, Neil, Wilkins, Alastair, Pearson, Owen R, Ziemssen, Tjalf, Hutchinson, Michael, Harding, Katharine, Jones, Joanne, McGuigan, Christopher, Butzkueven, Helmut, Kalincik, Tomas and Robertson, Neil 2019. Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis. Journal of the American Medical Association 321 (2) , pp. 175-187. 10.1001/jama.2018.20588

Harding, Katharine, Williams, Owain, Willis, Mark, Hrastelj, James, Rimmer, Anthony, Joseph, Fady, Tomassini, Valentina, Wardle, Mark, Pickersgill, Trevor, Robertson, Neil and Tallantyre, Emma 2019. Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis. JAMA Neurology 76 (5) , pp. 536-541. 10.1001/jamaneurol.2018.4905

Willis, Mark D, Hope-Gill, Ben, Flood-Page, Patrick, Joseph, Fady, Needham, Ed, Jones, Joanne, Coles, Alasdair and Robertson, Neil P 2018. Sarcoidosis following alemtuzumab treatment for multiple sclerosis. Multiple Sclerosis 24 (13) , 1779-`782. 10.1177/1352458518790391

Muller, Ilaria, Willis, Mark, Healy, Sarah, Nasser, Taha, Loveless, Samantha, Butterworth, Sara, Zhang, Lei, Draman Yusof, Mohd, Taylor, Peter, Robertson, Neil, Dayan, Colin and Ludgate, Marian 2018. Longitudinal characterization of autoantibodies to the thyrotropin receptor (TRAb) during alemtuzumab therapy; evidence that TRAb may precede thyroid dysfunction by many years. Thyroid 10.1089/thy.2018.0232

Harding, Katharine, Anderson, Valerie, Williams, Owain, Willis, Mark, Butterworth, Sara, Tallantyre, Emma, Joseph, Fady, Wardle, Mark, Pickersgill, Trevor and Robertson, Neil 2018. A contemporary study of mortality in the multiple sclerosis population of south east Wales. Multiple Sclerosis and Related Disorders 25 , pp. 186-191. 10.1016/j.msard.2018.08.001

Willis, M. D. and Robertson, N. P. 2018. Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease. Journal of Neurology 265 (8) , pp. 1950-1952. 10.1007/s00415-018-8963-z

Pariani, Nadia, Willis, Mark, Muller, Ilaria, Healy, Sarah, Nasser, Taha, McGowan, Anne, Lyons, Greta, Jones, Joanne, Chatterjee, Krishna, Dayan, Colin, Robertson, Neil, Coles, Alasdair and Moran, Carla 2018. Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features. Journal of Clinical Endocrinology & Metabolism 108 (8) , pp. 3010-3018. 10.1210/jc.2018-00359

Alsaeed, Meshari, Harding, Katharine, Williams, O. H., Willis, Mark, Hrastelj, James, Tallantyre, Emma, Joseph, Fady, Wardle, Mark, Pickersgill, T. P. and Robertson, Neil 2018. Multiple sclerosis: long-term outcomes in ethnic minorities. analysis of a UK population-based registry. European Journal of Neurology 25 (4) , pp. 701-704. 10.1111/ene.13571

Ved, Ronak, Cobbold, Naomi, Igbagiri, Kueniemugh, Willis, Mark, Leach, Paul and Zaben, Malik 2017. Online patient information on Vagus Nerve Stimulation: How reliable is it for facilitating shared decision making? Seizure - European Journal of Epilepsy 50 , pp. 125-129. 10.1016/j.seizure.2017.06.009

Willis, Mark D. and Robertson, Neil P. 2017. Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis. Journal of Neurology 264 (6) , pp. 1298-1300. 10.1007/s00415-017-8508-x

Harding, Katharine, Tilling, Kate, MacIver, Claire, Willis, Mark, Joseph, Fady, Ingram, Gillian, Hirst, Claire, Wardle, Mark, Pickersgill, Trevor, Ben-Shlomo, Yoav and Robertson, Neil 2017. Seasonal variation in multiple sclerosis relapse. Journal of Neurology 264 (6) , pp. 1059-1067. 10.1007/s00415-017-8485-0

Kalincik, Tomas, Brown, J William L, Robertson, Neil, Willis, Mark, Scolding, Neil, Rice, Claire M, Wilkins, Alastair, Pearson, Owen, Ziemssen, Tjalf, Hutchinson, Michael, McGuigan, Christopher, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Alroughani, Raed, Pucci, Eugenio, Sola, Patrizia, Hupperts, Raymond, Lechner-Scott, Jeannette, Terzi, Murat, Van Pesch, Vincent, Rozsa, Csilla, Grand'Maison, François, Boz, Cavit, Granella, Franco, Slee, Mark, Spitaleri, Daniele, Olascoaga, Javier, Bergamaschi, Roberto, Verheul, Freek, Vucic, Steve, McCombe, Pamela, Hodgkinson, Suzanne, Sanchez-Menoyo, Jose Luis, Ampapa, Radek, Simo, Magdolna, Csepany, Tunde, Ramo, Cristina, Cristiano, Edgardo, Barnett, Michael, Butzkueven, Helmut and Coles, Alasdair 2017. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. The Lancet Neurology 16 (4) , pp. 271-281. 10.1016/S1474-4422(17)30007-8

Willis, Mark, Pearson, Owen, Illes, Zsolt, Sejbaek, Tobias, Nielson, Christian, Duddy, Martin, Petheram, Kate, van Munster, Casper, Killestein, Joep, Malmestrom, Clas, Tallantyre, Emma and Robertson, Neil 2017. An observational study of alemtuzumab following fingolimod for multiple sclerosis. Neuroimmunology and Neuroinflammation 4 (2) , E320. 10.1212/NXI.0000000000000320

Willis, Mark 2017. A clinical and immunological study of CD8+ T cells in multiple sclerosis. PhD Thesis, Cardiff University.
Item availability restricted.

Clement, Mathew, Pearson, James, Gras, Stephanie, Van den berg, Hugo, Lissina, Anya, Llewellyn-Lacey, Sian, Willis, Mark, Dockree, Tamsin, McLaren, James, Ekeruche-Makinde, Julia, Gostick, Emma, Robertson, Neil, Burrows, Scott, Price, David, Wong, Florence, Peakman, Mark, Skowera, Ania and Wooldridge, Linda 2016. Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies. Scientific Reports 6 , 35332. 10.1038/srep35332

Willis, Mark, Pickersgill, Trevor, Robertson, Neil, Lee, Richard W. J., Dick, Andrew D. and Carreño, Ester 2016. Alemtuzumab-induced remission of multiple sclerosis-associated uveitis. International Ophthalmology 10.1007/s10792-016-0370-9

Willis, Mark and Robertson, Neil 2016. Alemtuzumab for multiple sclerosis. Current Neurology and Neuroscience Reports 16 , 84. 10.1007/s11910-016-0685-y

Willis, Mark, Harding, Katharine, Pickersgill, T., Wardle, Mark, Pearson, O., Scolding, N., Smee, J. and Robertson, Neil 2016. Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort. Multiple Sclerosis Journal 22 (9) , pp. 1215-1223. 10.1177/1352458515614092

Hirst, C. L., Willis, Mark, Hussain, H. and Powell, R. 2015. Acute myeloid leucaemia presenting as a rapidly progressive polyradiculoneuropathy. BMJ Case Reports 2015 , -. 10.1136/bcr-2015-209556

Healy, Sarah, Willis, Mark and Robertson, Neil Patrick 2015. Prognosis in multiple sclerosis and the unveiling of pathogenic clues. Journal of Neurology 262 (11) , pp. 2596-2598. 10.1007/s00415-015-7938-6

Willis, Mark, Harding, Katharine, Wardle, M., Pickersgill, T. P., Tomassini, Valentina, Loveless, Samantha and Robertson, Neil 2015. Site-specific clinical disease onset in multiple sclerosis. European Journal of Neurology 22 (4) , pp. 732-735. 10.1111/ene.12564

Willis, Mark and Robertson, Neil 2015. Alemtuzumab for the treatment of multiple sclerosis. Therapeutics and Clinical Risk Management 2015 (11) , pp. 525-534. 10.2147/TCRM.S80112

Willis, Mark and Robertson, Neil 2014. Drug safety evaluation of alemtuzumab for multiple sclerosis. Expert Opinion on Drug Safety 13 (8) , pp. 1115-1124. 10.1517/14740338.2014.928691

Willis, Mark, Jones, L., Vincent, A., Wheeler, R., O'Callaghan, P. and Hamandi, Khalid 2014. VGKC-complex antibody encephalitis. Qjm -Oxford- 107 (8) , pp. 657-659. 10.1093/qjmed/hcu030

Willis, Mark and Robertson, Neil 2014. Treatment paradigms in multiple sclerosis: who, when and how to treat? Journal of Neurology 261 (7) , pp. 1444-1446. 10.1007/s00415-014-7420-x

Willis, Mark, Amato-Watkins, T., Zaben, M., Baig, A., Corkill, R. and Joshi, Y. 2014. Reversible brainstem dysfunction from spinal arterio-venous fistula. Practical Neurology 14 (6) , pp. 425-428. 10.1136/practneurol-2014-000872

Willis, Mark and Robertson, Neil 2013. Amyotrophic lateral sclerosis: new hope for an old disease? Journal of Neurology 260 (9) , pp. 2441-3. 10.1007/s00415-013-7063-3

Willis, Mark, Rudge, P and Walters, RJ 2013. Subacute sclerosing panencephalitis: rapidly progressive cognitive decline in a young patient. British Journal of Hospital Medicine 74 (3) , pp. 172-173. 10.12968/hmed.2013.74.3.172

Willis, Mark and Robertson, Neil 2012. Aphasia: early classification, evaluation of existing therapy, and novel therapeutics. Journal of Neurology 259 (11) , pp. 2510-2512. 10.1007/s00415-012-6701-5

This list was generated on Fri Apr 3 04:24:35 2020 BST.